Chief Scientific Officer
Daniel founded BioOutsource in 2007 with a team which included some former colleagues from Q-One Biotech. As Chief Scientist he has developed a successful team which is now seen as one of the leading providers for bioanalytical services globally and has gained a reputation for successful contract research in the biosimilar industry.. He has also held senior positions in the fields of contract research (BioReliance Europe) and manufacturing (MedImmune). Daniel has a keen interest in Biosimilars and from his time with MedImmune working on the FluMist project he has retained an interest in virus vaccines.
Biosimilars, Monoclonal Antibodies and Virus Vaccines